SEC Info - Gene Biotherapeutics, Inc. - ‘8-K’ for 3/16/19

SEC Info℠

Home

Help

Please Sign In

Gene Biotherapeutics, Inc. – ‘8-K’ for 3/16/19

On: Wednesday, 3/20/19, at 6:15am ET · For: 3/16/19 · Accession #: 1493152-19-3612 · File #: 1-33635

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/20/19  Gene Biotherapeutics, Inc.        8-K:5,9     3/16/19    2:45K                                    M2 Compliance/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     16K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      8K

Filing Submission 0001493152-19-003612 – SGML Text

Original SGML Text submitted by:	M2 Compliance LLC/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Gene Biotherapeutics, Inc. – ‘8-K’ for 3/16/19

On: Wednesday, 3/20/19, at 6:15am ET · For: 3/16/19 · Accession #: 1493152-19-3612 · File #: 1-33635

Previous ‘8-K’: ‘8-K’ on 9/13/18 for 9/10/18 · Next: ‘8-K’ on 5/28/20 for 5/21/20 · Latest: ‘8-K/A’ on 8/9/21 for 8/6/21

Current Report — Form 8-KFiling Table of Contents

To view the SGML, please refresh this page.

Current Report — Form 8-K
Filing Table of Contents

To view the SGML, please refresh
this page.